dc.contributor
[Torné A] Central Catalonia Chronicity Research Group (C3RG), Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVIC-UCC), Barcelona, Spain. Departament de geriatria i cures pal·liatives, Hospital Universitari de la Santa Creu Barcelona, Spain. Departament de geriatria i cures pal·liatives, Hospital Universitari de Vic, Barcelona, Spain. [Puigoriol E] Clinical Epidemiology Unit, Consorci Hospitalari de Vic, Barcelona, Spain. Tissue Repair and Regeneration Laboratory (TR2Lab), Faculty of Sciences and Technology, Faculty of Medicine, University of Vic-Central University of Catalonia, Barcelona, Spain. [Zabaleta-del-Olmo E] Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Gerència Territorial de Barcelona, Institut Català de la Salut (ICS), Barcelona, Spain. Nursing Department, Faculty of Nursing, Universitat de Girona, Girona, Spain. [Zamora-Sánchez J-J] Gerència Territorial de Barcelona, Institut Català de la Salut (ICS), Barcelona, Spain. [Santaeugènia-Gonzàlez SJ] Central Catalonia Chronicity Research Group (C3RG), Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVIC-UCC), Barcelona, Spain. Programa de cures cròniques, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Amblàs-Novellas J] Central Catalonia Chronicity Research Group (C3RG), Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVIC-UCC), Barcelona, Spain. Geriatric and Palliative Care Department, Hospital Universitari de la Santa Creu Barcelona, Spain. Geriatric and Palliative Care Department, Hospital Universitari de Vic, Barcelona, Spain. Programa de cures cròniques, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
dc.contributor
IDIAP Jordi Gol
dc.contributor.author
Torné, Anna
dc.contributor.author
Puigoriol, Emma
dc.contributor.author
Zabaleta-del-Olmo, Edurne
dc.contributor.author
Zamora-Sánchez, Juan-José
dc.contributor.author
Santaeugènia-Gonzàlez, Sebastià J.
dc.contributor.author
Jordi, Amblàs-Novellas
dc.date.accessioned
2025-10-24T10:58:47Z
dc.date.available
2025-10-24T10:58:47Z
dc.date.issued
2021-05-25T11:28:04Z
dc.date.issued
2021-05-25T11:28:04Z
dc.date.issued
2021-05-13
dc.identifier
Torné A, Puigoriol E, Zabaleta-del-Olmo E, Zamora-Sánchez J-J, Santaeugènia S, Amblàs-Novellas J. Reliability, Validity and Feasibility of the Frail-VIG Index. Int J Environ Res Public Health. 2021;18(10):5187.
dc.identifier
https://hdl.handle.net/11351/5974
dc.identifier
10.3390/ijerph18105187
dc.identifier.uri
https://hdl.handle.net/11351/5974
dc.description.abstract
Frailty; Psychometrics; Feasibility
dc.description.abstract
Fragilitat; Psicometria; Viabilitat
dc.description.abstract
Fragilidad; Psicometría; Viabilidad
dc.description.abstract
The study aimed to assess the reliability of the scores, evidence of validity, and feasibility of the Frail-VIG index. A validation study mixing hospitalized and community-dwelling older people was designed. Intraclass correlation coefficient (ICC) was used to assess the inter-rater agreement and the reliability. The construct validity of the Frail-VIG index with respect to the Frailty Phenotype (FP) was evaluated by calculating the area under the receiver operating characteristic curve (AUC-ROC). Convergent validity with the Clinical Frailty Scale (CFS) was assessed using Pearson’s correlation coefficients. The feasibility was evaluated by calculating the average time required to administer the Frail-VIG index and the percentage of unanswered responses. A sample of 527 older people (mean age of 81.61, 56.2% female) was included. The inter-rater agreement and test–retest reliability were very strong: 0.941 (95% CI, 0.890 to 0.969) and 0.976 (95% CI, 0.958 to 0.986), respectively. Results indicated adequate convergent validity of the Frail-VIG index with respect to the FP, AUC-ROC 0.704 (95% CI, 0.622 to 0.786), and a moderate to strong positive correlation between the Frail-VIG index and CFS (r = 0.635, 95% CI, 0.54 to 0.71). The Frail-VIG index administration required an average of 5.01 min, with only 0.34% of unanswered responses. The Frail-VIG index is a reliable, feasible, and valid instrument to assess the degree of frailty in hospitalized and community-dwelling older people.
dc.format
application/pdf
dc.relation
International Journal of Environmental Research and Public Health;18(10)
dc.relation
https://www.mdpi.com/1660-4601/18/10/5187
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Persones grans dependents
dc.subject
Indicadors de salut
dc.subject
DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Frailty
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires::Health Surveys::Health Status Indicators
dc.subject
ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::fragilidad
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios::encuestas de salud::indicadores de salud
dc.title
Reliability, Validity, and Feasibility of the Frail-VIG Index
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion